Citation: Fj. Ehlert et Mt. Griffin, THE USE OF IRREVERSIBLE LIGANDS TO INACTIVATE RECEPTOR SUBTYPES - 4-DAMP MUSTARD AND MUSCARINIC RECEPTORS IN SMOOTH-MUSCLE, Life sciences, 62(17-18), 1998, pp. 1659-1664
Citation: Rs. Ostrom et Fj. Ehlert, M-2 MUSCARINIC RECEPTORS INHIBIT FORSKOLIN - BUT NOT ISOPROTERENOL-MEDIATED RELAXATION IN BOVINE TRACHEAL SMOOTH-MUSCLE, The Journal of pharmacology and experimental therapeutics, 286(1), 1998, pp. 234-242
Citation: Gw. Sawyer et Fj. Ehlert, CONTRACTILE ROLES OF THE M-2 AND M-3 MUSCARINIC RECEPTORS IN THE GUINEA-PIG COLON, The Journal of pharmacology and experimental therapeutics, 284(1), 1998, pp. 269-277
Citation: Mt. Griffin et al., THE INTERACTIONS OF THE ENANTIOMERS OF ACECLIDINE WITH SUBTYPES OF THE MUSCARINIC RECEPTOR, Life sciences, 60(13-14), 1997, pp. 26-26
Citation: Rs. Ostrom et Fj. Ehlert, M(2) MUSCARINIC RECEPTOR INHIBITION OF AGONIST-INDUCED CYCLIC ADENOSINE-MONOPHOSPHATE ACCUMULATION AND RELAXATION IN THE GUINEA-PIG ILEUM, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 189-199
Authors:
BURKEY TH
QUOCK RM
CONSROE P
EHLERT FJ
HOSOHATA Y
ROESKE WR
YAMAMURA HI
Citation: Th. Burkey et al., RELATIVE EFFICACIES OF CANNABINOID CB1 RECEPTOR AGONISTS IN THE MOUSE-BRAIN, European journal of pharmacology, 336(2-3), 1997, pp. 295-298
Citation: Fj. Ehlert et al., THE INTERACTION OF THE ENANTIOMERS OF ACECLIDINE WITH SUBTYPES OF THEMUSCARINIC RECEPTOR, The Journal of pharmacology and experimental therapeutics, 279(3), 1996, pp. 1335-1344
Citation: Fj. Ehlert et al., THE QUATERNARY TRANSFORMATION PRODUCTS OF N-(3-CHLOROPROPYL)-4-PIPERIDINYL DIPHENYLACETATE AND N-(2-CHLOROETHYL)-4-PIPERIDINYL DIPHENYLACETATE (4-DAMP MUSTARD) HAVE DIFFERENTIAL AFFINITY FOR SUBTYPES OF THE MUSCARINIC RECEPTOR, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 405-410
Authors:
ESQUEDA EE
GERSTIN EH
GRIFFIN MT
EHLERT FJ
Citation: Ee. Esqueda et al., STIMULATION OF CYCLIC-AMP ACCUMULATION AND PHOSPHOINOSITIDE HYDROLYSIS BY M(3) MUSCARINIC RECEPTORS IN THE RAT PERIPHERAL LUNG, Biochemical pharmacology, 52(4), 1996, pp. 643-658
Citation: Ea. Thomas et Fj. Ehlert, INVOLVEMENT OF THE M(2) MUSCARINIC RECEPTOR IN CONTRACTIONS OF THE GUINEA-PIG TRACHEA, GUINEA-PIG ESOPHAGUS, AND RAT FUNDUS, Biochemical pharmacology, 51(6), 1996, pp. 779-788
Citation: Eh. Gerstin et Fj. Ehlert, INHIBITION OF MUSCARINIC STIMULATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT PAROTID-GLAND BY CAMP, Life sciences, 58(2), 1995, pp. 145-153
Citation: Eh. Gerstin et Fj. Ehlert, EVIDENCE FOR MUSCARINIC RECEPTOR CROSS-TALK IN THE RAT PAROTID-GLAND, Life sciences, 56(11-12), 1995, pp. 1023-1023
Citation: Ee. Esqueda et Fj. Ehlert, MUSCARINIC RECEPTORS MEDIATE A MASS INCREASE IN CYCLIC-AMP IN THE RATPERIPHERAL LUNG, Life sciences, 56(11-12), 1995, pp. 1024-1024
Citation: Ea. Thomas et Fj. Ehlert, M(2) MUSCARINIC RECEPTORS CAN MEDIATE CONTRACTIONS OF THE GUINEA-PIG TRACHEA IN THE PRESENCE OF INDOMETHACIN, Life sciences, 56(11-12), 1995, pp. 1043-1043
Citation: Eh. Gerstin et al., A PHARMACOLOGICAL CHARACTERIZATION OF MUSCARINIC RECEPTOR SUBTYPES MEDIATING AN INCREASE IN C'-AMP ACCUMULATION AND PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT PERIPHERAL LUNG, The FASEB journal, 8(4), 1994, pp. 10000088-10000088
Citation: Fj. Ehlert et al., MUSCARINIC RECEPTORS AND NOVEL STRATEGIES FOR THE TREATMENT OF AGE-RELATED BRAIN DISORDERS, Life sciences, 55(25-26), 1994, pp. 2135-2145
Citation: Ea. Thomas et Fj. Ehlert, PERTUSSIS TOXIN BLOCKS M(2) MUSCARINIC RECEPTOR-MEDIATED EFFECTS ON CONTRACTION AND CYCLIC-AMP IN THE GUINEA-PIG ILEUM, BUT NOT M(3)-MEDIATED CONTRACTIONS AND PHOSPHOINOSITIDE HYDROLYSIS, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 1042-1050
Citation: Ea. Thomas et al., FUNCTIONAL-ROLE OF THE M(2)-MUSCARINIC RECEPTOR IN SMOOTH-MUSCLE OF GUINEA-PIG ILEUM, Molecular pharmacology, 44(1), 1993, pp. 102-110
Citation: Mt. Griffin et al., KINETICS OF ACTIVATION AND IN-VIVO MUSCARINIC RECEPTOR-BINDING OF N-(2-BROMOETHYL)-4-PIPERIDINYL DIPHENYLACETATE - AN ANALOG OF 4-DAMP MUSTARD, The Journal of pharmacology and experimental therapeutics, 266(1), 1993, pp. 301-305